Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial.

Saved in:
Bibliographic Details
Title: Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial.
Authors: Lee CN; Department of Ophthalmology, King's College Hospital, London, UK., Desai R; Department of Ophthalmology, King's College Hospital, London, UK., Ramazzotto L; Faculty of Life Sciences and Medicine, King's College London, London, UK., Wafa H; Population Health Sciences, Faculty and Life Science and Medicine, King's College London, London, UK., Wang Y; Population Health Sciences, Faculty and Life Science and Medicine, King's College London, London, UK., Bunce C; The London School of Hygiene and Tropical Medicine, London, UK., Doungsong K; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales., Ezeofor V; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales., Edwards RT; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales., Lois N; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland., Steel DH; Bioscience Institute, Newcastle University, Newcastle, UK., Peto T; Network of Ophthalmic Reading Centres UK, Queen's University, Belfast, Northern Ireland., Hillenkamp J; Eye Clinic, University of Wurzburg, Wurzburg, Germany., van Meurs JC; Rotterdam Eye Hospital and Erasmus Medical Centre, Rotterdam, the Netherlands., Reeves BC; University of Bristol, Bristol, UK., Jackson TL; Faculty of Life Sciences and Medicine, King's College London, London, UK. t.jackson1@nhs.net.
Source: Trials [Trials] 2025 Apr 14; Vol. 26 (1), pp. 131. Date of Electronic Publication: 2025 Apr 14.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1745-6215
DOI:10.1186/s13063-025-08727-8